awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36355098-3761AAB3-E38C-4C27-BC2D-C9C0C01C00EA
Q36355098-3761AAB3-E38C-4C27-BC2D-C9C0C01C00EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36355098-3761AAB3-E38C-4C27-BC2D-C9C0C01C00EA
Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy.
P2860
Q36355098-3761AAB3-E38C-4C27-BC2D-C9C0C01C00EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36355098-3761AAB3-E38C-4C27-BC2D-C9C0C01C00EA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ee6fa58daf42e1d06bcd280815ad378f45f76d6
P2860
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.